. Author manuscript; available in PMC: 2010 Dec 1.

Published in final edited form as: Clin Cancer Res. 2009 Nov 17;15(23):7238–7245. doi: 10.1158/1078-0432.CCR-09-1964

Table 2.

Secondary screening by AnnexinV/PI staining % conferred reduction compared to vehicle controls is shown. Only the compounds with statistically significant reduction in apoptosis in W-T or A-T LCLs are shown (P < 0.05).

Compound (µM)	W-T	A-T
tetracycline (20)	19	NS
norfloxacin (40)	28	28
levofloxacin (40)	16	34
doxycycline (10)	NS	31
chlorotetracycline (20)	NS	48
moxifloxacin (10)	NS	50
ciprofloxacin (5)	21	NS
flumequine (100)	25	37
enoxacin (100)	18	NS
5’-AMP (20)	34	13

NS=not significant